New cytotoxic agents: a review of the literatureHOTTA, Katsuyuki; UEOKA, Hiroshi.Critical reviews in oncology/hematology. 2005, Vol 55, Num 1, pp 45-65, issn 1040-8428, 21 p.Article

Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported casesFUJIMOTO, Nobukazu; HIRAKI, Akio; UEOKA, Hiroshi et al.Lung cancer. 2001, Vol 34, Num 1, pp 149-152, issn 0169-5002Article

An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; KIURA, Katsuyuki et al.Lung cancer. 2004, Vol 46, Num 1, pp 61-76, issn 0169-5002, 16 p.Article

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2008, Vol 62, Num 2, pp 236-241, issn 0169-5002, 6 p.Article

Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancerHOTTA, Katsuyuki; MATSUO, Keitaro; UEOKA, Hiroshi et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3852-3859, issn 0732-183X, 8 p.Article

Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer : Reappraisal with a meta-analysis of randomized controlled trialsHOTTA, Katsuyuki; MATSUO, Keitaro; UEOKA, Hiroshi et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3860-3867, issn 0732-183X, 8 p.Article

Thrombocytosis as a useful prognostic indicator in patients with lung cancerAOE, Keisuke; HIRAKI, Akio; UEOKA, Hiroshi et al.Respiration (Basel). 2004, Vol 71, Num 2, pp 170-173, issn 0025-7931, 4 p.Article

Axillary metastasis as the first manifestation of occult breast cancer in a man: A case reportNAMBA, Noriko; HIRAKI, Akio; TABATA, Masahiro et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3611-3613, issn 0250-7005, 3 p.Article

Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of IrinotecanANDO, Yuichi; UEOKA, Hiroshi; SUGIYAMA, Toru et al.Therapeutic drug monitoring. 2002, Vol 24, Num 1, pp 111-116, issn 0163-4356Conference Paper

Aberrant promoter hypermethylation in serum DNA from patients with silicosisUMEMURA, Shigeki; FUJIMOTO, Nobukazu; UEOKA, Hiroshi et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 9, pp 1845-1849, issn 0143-3334, 5 p.Article

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationHOTTA, Katsuyuki; TABATA, Masahiro; TANIMOTO, Mitsune et al.Oncology reports. 2007, Vol 17, Num 2, pp 313-317, issn 1021-335X, 5 p.Article

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapyHOTTA, Katsuyuki; FUJIWARA, Yoshiro; MATSUO, Keitaro et al.Cancer. 2007, Vol 109, Num 5, pp 939-948, issn 0008-543X, 10 p.Article

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masako; KIURA, Katsuyuki et al.Oncology reports. 2006, Vol 15, Num 4, pp 837-842, issn 1021-335X, 6 p.Article

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; TANIMOTO, Mitsune et al.Lung cancer. 2004, Vol 45, Num 1, pp 77-84, issn 0169-5002, 8 p.Article

Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemiaHIRAKI, Akio; UEOKA, Hiroshi; BESSHO, Akihiro et al.Cancer. 2002, Vol 95, Num 8, pp 1706-1713, issn 0008-543X, 8 p.Article

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancerTAKIGAWA, Nagio; SEGAWA, Yoshihiko; UEOKA, Hiroshi et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 4, pp 272-278, issn 0344-5704Article

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsTAO, Hiroyuki; MIMURA, Yusuke; AOE, Keisuke et al.Lung cancer. 2012, Vol 75, Num 1, pp 95-101, issn 0169-5002, 7 p.Article

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer : Experience at a single institutionMATSUO, Keitaro; KIURA, Katsuyuki; SHINAGAWA, Katsuji et al.American journal of hematology. 2006, Vol 81, Num 5, pp 349-354, issn 0361-8609, 6 p.Article

Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabineOHASHI, Kadoaki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Anticancer research. 2006, Vol 26, Num 6C, pp 4695-4696, issn 0250-7005, 2 p.Article

Identification of epigenetic aberrant promoter Methylation in serum DNA is useful for early detection of lung cancerFUJIWARA, Keiichi; FUJIMOTO, Nobukazu; TANIMOTO, Mitsune et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1219-1225, issn 1078-0432, 7 p.Article

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancersTOKUMO, Masaki; TOYOOKA, Shinichi; TABATA, Masahiro et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1167-1173, issn 1078-0432, 7 p.Article

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsTAKIGAWA, Nagio; SEGAWA, Yoshihiko; GEMBA, Kenichi et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 3, pp 230-236, issn 0344-5704, 7 p.Article

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancerSEGAWA, Yoshihiko; UEOKA, Hiroshi; HIRAKI, Shunkichi et al.Lung cancer. 2003, Vol 41, Num 1, pp 13-20, issn 0169-5002, 8 p.Article

Effect of nebulized furosemide in terminally ill cancer patients with dyspneaKOHARA, Hiroyuki; UEOKA, Hiroshi; AOE, Keisuke et al.Journal of pain and symptom management. 2003, Vol 26, Num 4, pp 962-967, issn 0885-3924, 6 p.Article

Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell lineKOHARA, Hiroyuki; TABATA, Masahiro; KIURA, Katsuyuki et al.Clinical cancer research. 2002, Vol 8, Num 1, pp 287-292, issn 1078-0432Article